Financials
- Market Capitalization 165.67 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.an2therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QYLYBK4
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3736 | IPHA Innate Pharma S.A. - American Depositary Shares | 1.80 USD | -1.10% | -2.17% | -2.17% | 0.00% | 168.69 M USD | ||
| 3744 | CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 8.91 USD | -1.33% | -3.57% | +7.35% | -46.33% | 165.08 M USD | ||
| 3748 | ALEC Alector, Inc. - Common Stock | 1.49 USD | +7.19% | -18.13% | +1.36% | -6.29% | 165.43 M USD | ||
| 3758 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.27 USD | -10.28% | -14.34% | -2.99% | +70.68% | 163.96 M USD |
Frequently asked questions about AN2 Therapeutics, Inc. - Common Stock
What is the AN2 Therapeutics, Inc. - Common Stock stock price today?
The current price of AN2 Therapeutics, Inc. - Common Stock (ANTX) is 4.6. Over the past 24 hours, the stock has changed by -3.36%. Follow the ANTX chart for real-time price dynamics.
What is the stock ticker of AN2 Therapeutics, Inc. - Common Stock?
AN2 Therapeutics, Inc. - Common Stock trades under the ticker ANTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AN2 Therapeutics, Inc. - Common Stock stock going up?
ANTX has changed by +5.75% over the last week, -6.69% over the last month, and +333.96% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does AN2 Therapeutics, Inc. - Common Stock release financial reports?
Yes. You can track AN2 Therapeutics, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was AN2 Therapeutics, Inc. - Common Stock net income for the last quarter?
AN2 Therapeutics, Inc. - Common Stock reported net income of -10.03 M for the last quarter. The previous quarter showed -8.71 M, which means net income changed by -15.13%.
How many employees does AN2 Therapeutics, Inc. - Common Stock have?
As of the latest available data, AN2 Therapeutics, Inc. - Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy AN2 Therapeutics, Inc. - Common Stock stock?
You can buy AN2 Therapeutics, Inc. - Common Stock (ANTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AN2 Therapeutics, Inc. - Common Stock stock?
Investing in AN2 Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANTX chart and related analysis on metatrader.com as part of your research.